This video introduces the commercial practice of relabelling research antibodies for resale and explains its negative implications.
1. Economics of reproducibility in pre-clinical research.
2. Drug Development: Raise standards for preclinical cancer research.
3. 1,500 scientists lift the lid on reproducibility.
4. A Genecentric Human Protein Atlas for Expression Profiles Based on Antibodies.
5. Reproducibility: Standardize antibodies used in research.
6. 1st International Antibody Validation Forum 2014: Jan Voskuil.
7. Reproducibility crisis: Blame it on the antibodies.
8. Abcam Annual Report 2016.
9. Sigma Aldrich Annual Report 2014.